tert-Butyl piperazine-1-carboxylate → (S)-tert-Butyl 1-(oxetan-3-yl)pyrrolidin-3-ylcarbamate
Reaction equation
[N:1]1([C:7]([O:9][C:10]([CH3:13])([CH3:12])[CH3:11])=[O:8])[CH2:6][CH2:5][NH:4][CH2:3][CH2:2]1.[O:14]1[CH2:17][C:16](=O)[CH2:15]1.ClC1C=CC(C2C(C=O)=CC=CC=2)=CC=1>>[O:14]1[CH2:17][CH:16]([N:4]2[CH2:3][CH2:2][C@H:6]([NH:1][C:7](=[O:8])[O:9][C:10]([CH3:11])([CH3:12])[CH3:13])[CH2:5]2)[CH2:15]1Participants
4
Procedure
The title compound was prepared by substituting (S)-tert-butyl pyrrolidin-3-ylcarbamate for tert-butyl piperazine-1-carboxylate and 3-oxetanone for 4′-chlorobiphenyl-2-carboxaldehyde in EXAMPLE 1A.
Sources & evidence
- ORD record
- ord-495660d510254533990be834bfe2d4b4
- Source dataset
- uspto-grants-2013_11
- Patent number
- US08580794B2
Reaction notes
Loading…